340023-82-7

Basic information

• Product Name: 3,3-[1,2-ethanediylbis(oxy)]-11β-{4-{1,1-[1,2-ethanediylbis(oxy)]ethyl}phenyl}-5α-hydroxy-17α-(3-hydroxypropyl)-19-norpregn-9-en-20-one
• Synonyms: 3,3-[1,2-ethanediylbis(oxy)]-11β-{4-{1,1-[1,2-ethanediylbis(oxy)]ethyl}phenyl}-5α-hydroxy-17α-(3-hydroxypropyl)-19-norpregn-9-en-20-one
• CAS NO: 340023-82-7
• Molecular Weight: 580.762
• Mol File: 340023-82-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3,3-[1,2-ethanediylbis(oxy)]-11β-{4-{1,1-[1,2-ethanediylbis(oxy)]ethyl}phenyl}-5α-hydroxy-17α-(3-hydroxypropyl)-19-norpregn-9-en-20-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3,3-[1,2-ethanediylbis(oxy)]-11β-{4-{1,1-[1,2-ethanediylbis(oxy)]ethyl}phenyl}-5α-hydroxy-17α-(3-hydroxypropyl)-19-norpregn-9-en-20-one(340023-82-7)
• EPA Substance Registry System: 3,3-[1,2-ethanediylbis(oxy)]-11β-{4-{1,1-[1,2-ethanediylbis(oxy)]ethyl}phenyl}-5α-hydroxy-17α-(3-hydroxypropyl)-19-norpregn-9-en-20-one(340023-82-7)

Safety Data

• Hazardous Substances Data: 340023-82-7(Hazardous Substances Data)

Upstream product

• 340023-79-2 3,3-[1,2-ethanediylbis(oxy)]-17α-(3-hydroxypropyl)-19-norpregna-5(10),9(11)-dien-20-one 
• 340023-75-8 17α-allyl-3,3-[1,2-ethanediylbis(oxy)]-20-hydroxy-19-norpregna-5(10),9(11)-diene 
• 340023-77-0 17α-allyl-3,3-[1,2-ethanediylbis(oxy)]-19-norpregna-5(10),9(11)-dien-20-one 
• 340023-71-4 17α-allyl-17β-cyano-3,3-[1,2-ethanediylbis(oxy)]estra-5(10),9(11)-diene 
• 340023-73-6 17α-allyl-3,3-[1,2-ethanediylbis(oxy)]-17β-formylestra-5(10),9(11)-diene 
• 240806-36-4 17-cyano-3,3-[1,2-ethanediylbis(oxy)]estra-5⁽¹⁰⁾,9⁽¹¹⁾-diene 
• 39575-67-2 (4-(2-methyl-1,3-dioxolan-2-yl)phenyl)magnesium bromide 
• 340023-80-5 3,3-[1,2-ethanediylbis(oxy)]-17α-(3-hydroxypropyl)-5,10-oxido-19-norpregn-9-en-20-one 
• 5571-36-8 ethylene deltenone 

Relevant articles and documents

Effect of a 17α-(3-hydroxypropyl)-17β-acetyl substituent pattern on the glucocorticoid and progestin receptor binding of 11β-arylestra-4,9-dien-3-ones

(matrix presented) Replacing the 17α-acetoxy substituent in an antiprogestational 17β-acetyl-11β-arylestra-4,9-dien-3-one by 3-hydroxypropyl significantly diminished glucocorticoid receptor binding with little effect on progestin receptor binding.